Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-108703
Filing Date
2024-10-15
Accepted
2024-10-15 17:49:12
Documents
1
Period of Report
2024-10-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2426125-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2426125-5_4seq1.xml 4 23390
  Complete submission text file 0001104659-24-108703.txt   24896
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Nashat Amir (Reporting) CIK: 0001575843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42365 | Film No.: 241372895

Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Issuer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)